Paracentesis before intravitreal injection of bevacizumab.

@article{Tsui2008ParacentesisBI,
  title={Paracentesis before intravitreal injection of bevacizumab.},
  author={Yung-Ping Tsui and Chun-Chi Chiang and Y L Tsai},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2008},
  volume={43 2},
  pages={239; author reply 239-40}
}
In their article, Hollands et al.1 evaluated the short-term intraocular pressure (IOP) changes after intravitreal injection of bevacizumab (Avastin, Genentech Inc, San Francisco, Calif.). They reported that elevated IOP after 30 minutes of observation might occur in a small number of patients, and that clinicians should consider checking IOP after injection as a precaution or should perform a preinjection paracentesis as prophylaxis.1 There are some points that we would like to add in the case… CONTINUE READING